Recent Posts

Pfizer quarterly results hit by soft demand for COVID-19 products

Pfizer CEO Albert Bourla discusses the pharma company’s next big drug after its COVID vaccine on ‘The Claman Countdown.’ Pfizer on Tuesday reported its first quarterly loss since 2019 as demand for its COVID products dwindled. Sales of the company’s coronavirus vaccine Comirnaty dropped 70% during the third quarter compared …

Read More »
The Ultimate Managed Hosting Platform
Verified by MonsterInsights